Genmab | GEN - Zapasy





Zapasy Zmiana Data
Agios Pharmaceuticals USD 35.09M 2.17M 2026-03
Almirall EUR 178.13M 1.54M 2025-12
Amarin USD 183.58M 12.32M 2026-03
Amgen USD 6.19B 39M 2026-03
argenx SE USD 473.53M 132.91M 2025-12
AstraZeneca USD 6.57B 13M 2026-03
Bayer EUR 12.34B 3M 2025-12
BioMarin Pharmaceutical USD 1.27B 25.66M 2026-03
Demant DKK 2.62B 78M 2025-12
Exelixis USD 26.6M 4.92M 2026-03
Fresenius Medical Care EUR 2.3B 162.24M 2026-03
Genmab DKK 13M 1000K 2025-06
GlaxoSmithKline GBP 6.16B 233M 2026-03
GN Store Nord DKK 2.31B 62M 2025-12
GRIFOLS EUR 3.35B 213.23M 2025-06
Hikma Pharmaceutical USD 1.08B 96M 2025-06
Insmed USD 132.91M 841K 2026-03
Lakefront Biotherapeutics EUR 17.69M 4.8M 2026-03
Lonza CHF 1.68B 163M 2025-12
Merck EUR 4.56B 52M 2025-12
Novartis USD 6.29B 17M 2026-03
Regeneron Pharmaceuticals USD 3.1B 97.2M 2026-03
Roche Holding CHF 7.6B 9M 2025-06
Sanofi EUR 22.69B 1.81B 2025-12
UCB EUR 1.31B 173M 2024-12